![](/img/cover-not-exists.png)
EP-1351: PHASE I/II trial of 3DCRT+MDR Brachy given concurrently to Caelyx and CDDP to high risk endometrial cancer patients
Varveris, C., Varveris, A., Mazonaki, M., Stratakis, J., Spanakis, A., Drakou, E., Potouridis, A.Volume:
111
Year:
2014
Language:
english
Journal:
Radiotherapy and Oncology
DOI:
10.1016/S0167-8140(15)31469-9
File:
PDF, 93 KB
english, 2014